Infections Associated With the Use of Alemtuzumab

Asian Multinational Retrospective Analysis for Infectious Complications in Patients Treated With Alemtuzumab

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01315457

Enrollment

182

Registered

2011-03-15

Start date

2009-04-30

Completion date

2012-03-31

Last updated

2012-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Treated With Alemtuzumab

Keywords

alemtuzumab, infection, prophylaxis, treatment

Brief summary

The aim of this study is to propose infection prophylaxis from Asian multinational retrospective analysis of infectious complications in patients who were treated with alemtuzumab

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

15 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Patients received alemtuzumab as a treatment for hematologic malignancy ex. non-Hodgkin lymphoma Acute myeloid leukemia Aplastic anemia

Exclusion criteria

* Patients did not receive alemtuzumab

Design outcomes

Primary

Measure	Time frame	Description
Infectious event	one year	Any infectious complication occurred within one year after the use of alemtuzumab

Countries

China, Indonesia, South Korea, Taiwan, Thailand

Outcome results